By THE ASSOCIATED PRESS
A jury upheld the validity of Merck patents in a dispute with Gilead Sciences, which could be forced to hand over a portion of the billions of dollars it has made on hepatitis C drugs.
Published: March 23, 2016 at 12:00AM
from NYT Business Day http://ift.tt/1o5j8MF
from WordPress http://ift.tt/1RyiIw9
via Hadi Aboukhater
No comments:
Post a Comment